4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study | Charles Explorer

4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study

Publication at First Faculty of Medicine |

2004

Abstract

breast cancer, HER2/Neu overexpression, transtuzumab, paklitaxel

People